TIDMC4XD

RNS Number : 1891O

C4X Discovery Holdings PLC

29 September 2023

C4X Discovery Holdings plc

("C4XD", "C4X Discovery" or the "Company")

Grant of Options and Directors Dealing

29 September 2023 - C4X Discovery Holdings plc (AIM: C4XD), a pioneering Drug Discovery company, today announces that a total of 5,950,000 options over ordinary shares of the Company were awarded pursuant to the 2014 Share Option Plan to certain employees, which includes 400,000 options each to Dr Clive Dix, Chief Executive Officer, Brad Hoy, Chief Financial Officer and Bhavna Hunjan, Chief Business Officer as set out below.

 
 Director         Position           Number of        Option exercise   Total number 
                                      share options    price per         of options 
                                      awarded          share (pence)     held 
                  Chief Executive 
 Dr Clive Dix      Officer           400,000          15.1              1,245,000 
                 -----------------  ---------------  ----------------  ------------- 
                  Chief Financial 
 Brad Hoy          Officer           400,000          15.1              1,400,000 
                 -----------------  ---------------  ----------------  ------------- 
                  Chief Business 
 Bhavna Hunjan     Officer           400,000          15.1              1,255,556 
                 -----------------  ---------------  ----------------  ------------- 
 

The options have an exercise price of 15.1 pence, being the average 5-day VWAP of the ordinary shares prior to the 29 September 2023. The options can be exercised at any time between three and ten years of them being granted.

The notification below, made in accordance with the requirements of the UK Market Abuse Regulation, provides further detail.

Notification and public disclosure of transactions by person discharging managerial responsibilities and persons closely associated with them.

 
 1     Details of the person discharging managerial responsibilities/person 
        closely associated 
 a)    Name(s)                                                       Dr Clive Dix 
      ------------------------------------------------------------  -------------------------------------------- 
 2     Reason for the notification 
      ---------------------------------------------------------------------------------------------------------- 
                                                                     Chief Executive Officer, Director 
  a)    Position/status 
      ------------------------------------------------------------  -------------------------------------------- 
 b)    Initial notification/Amendment                                Initial Notification 
      ------------------------------------------------------------  -------------------------------------------- 
 3     Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
      ---------------------------------------------------------------------------------------------------------- 
 a)    Name                                                          C4X Discovery Holdings plc 
      ------------------------------------------------------------  -------------------------------------------- 
 b)    LEI                                                           213800UHNL82E323O870 
      ------------------------------------------------------------  -------------------------------------------- 
 4     Details of the transaction(s): section to be repeated for (i) 
        each type of instrument; (ii) each type of transaction; (iii) 
        each date; and (iv) each place where transactions have been conducted 
      ---------------------------------------------------------------------------------------------------------- 
 a)    Description of the financial instrument, type of instrument   Options over ordinary shares of one penny 
                                                                      (GBP0.01) each in the share capital of the 
        Identification code                                           Company - EMI 2014 Plan 
 
                                                                      ISIN GB00BQQ2RV18 
      ------------------------------------------------------------  -------------------------------------------- 
 b)    Nature of the transaction                                     Grant of options over ordinary shares 
      ------------------------------------------------------------  -------------------------------------------- 
 c)    Price(s) and volume(s)                                         Price(s)   Volume(s) 
                                                                       15.1p      400,000 
                                                                      =========  ========== 
      ------------------------------------------------------------  -------------------------------------------- 
 d)    Aggregated information 
      ------------------------------------------------------------  -------------------------------------------- 
 e)    Date of the transaction                                       29 September 2023 
      ------------------------------------------------------------  -------------------------------------------- 
 f)    Place of the transaction                                      London Stock Exchange - AIM 
      ------------------------------------------------------------  -------------------------------------------- 
 
 
 1     Details of the person discharging managerial responsibilities/person 
        closely associated 
 a)    Name                              Brad Hoy 
      --------------------------------  ------------------------------------------ 
 2     Reason for the notification 
      ---------------------------------------------------------------------------- 
                                         Chief Financial Officer, Director 
  a)    Position/status 
      --------------------------------  ------------------------------------------ 
 b)    Initial notification/Amendment    Initial Notification 
      --------------------------------  ------------------------------------------ 
 3     Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
      ---------------------------------------------------------------------------- 
 a)    Name                              C4X Discovery Holdings plc 
      --------------------------------  ------------------------------------------ 
 b)    LEI                               213800UHNL82E323O870 
      --------------------------------  ------------------------------------------ 
 4     Details of the transaction(s): section to be repeated for (i) 
        each type of instrument; (ii) each type of transaction; (iii) 
        each date; and (iv) each place where transactions have been conducted 
      ---------------------------------------------------------------------------- 
 a)    Description of the financial      Options over ordinary shares of one penny 
        instrument, type of instrument    (GBP0.01) each in the share capital of 
                                          the Company - EMI 2014 Plan 
        Identification code 
                                          ISIN GB00BQQ2RV18 
      --------------------------------  ------------------------------------------ 
 b)    Nature of the transaction         Grant of options over ordinary shares 
      --------------------------------  ------------------------------------------ 
 c)    Price(s) and volume(s)             Price(s)   Volume(s) 
                                           15.1p      400,000 
                                          =========  ========== 
      --------------------------------  ------------------------------------------ 
 d)    Aggregated information 
      --------------------------------  ------------------------------------------ 
 e)    Date of the transaction           29 September 2023 
      --------------------------------  ------------------------------------------ 
 f)    Place of the transaction          London Stock Exchange - AIM 
      --------------------------------  ------------------------------------------ 
 
 
 1     Details of the person discharging managerial responsibilities/person 
        closely associated 
 a)    Name                              Bhavna Hunjan 
      --------------------------------  ------------------------------------------ 
 2     Reason for the notification 
      ---------------------------------------------------------------------------- 
                                         Chief Business Officer, Director 
  a)    Position/status 
      --------------------------------  ------------------------------------------ 
 b)    Initial notification/Amendment    Initial Notification 
      --------------------------------  ------------------------------------------ 
 3     Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
      ---------------------------------------------------------------------------- 
 a)    Name                              C4X Discovery Holdings plc 
      --------------------------------  ------------------------------------------ 
 b)    LEI                               213800UHNL82E323O870 
      --------------------------------  ------------------------------------------ 
 4     Details of the transaction(s): section to be repeated for (i) 
        each type of instrument; (ii) each type of transaction; (iii) 
        each date; and (iv) each place where transactions have been conducted 
      ---------------------------------------------------------------------------- 
 a)    Description of the financial      Options over ordinary shares of one penny 
        instrument, type of instrument    (GBP0.01) each in the share capital of 
                                          the Company - EMI 2014 Plan 
        Identification code 
                                          ISIN GB00BQQ2RV18 
      --------------------------------  ------------------------------------------ 
 b)    Nature of the transaction         Grant of options over ordinary shares 
      --------------------------------  ------------------------------------------ 
 c)    Price(s) and volume(s)             Price(s)   Volume(s) 
                                           15.1p      400,000 
                                          =========  ========== 
      --------------------------------  ------------------------------------------ 
 d)    Aggregated information 
      --------------------------------  ------------------------------------------ 
 e)    Date of the transaction           29 September 2023 
      --------------------------------  ------------------------------------------ 
 f)    Place of the transaction          London Stock Exchange - AIM 
      --------------------------------  ------------------------------------------ 
 

- Ends -

Contacts

 
 C4X Discovery Holdings 
 Mo Noonan, Communications                    +44 (0)787 6444977 
 
 Panmure Gordon (UK) Limited (NOMAD and 
  Broker) 
 Freddy Crossley, Emma Earl (Corporate 
  Finance)                                    +44 (0)20 7886 2500 
 Rupert Dearden (Corporate Broking) 
 
 C4X Discovery Media - Consilium Strategic 
  Communications 
 Mary-Jane Elliott, Chris Gardner, Matthew 
  Neal                                        +44 (0)203 709 5700 
 

Notes to Editors:

About C4X Discovery

C4X Discovery ("C4XD") is a pioneering Drug Discovery company combining scientific expertise with cutting-edge Drug Discovery technologies to efficiently deliver world leading medicines, which are developed by our partners for the benefit of patients. We have a highly valuable and differentiated approach to Drug Discovery through our enhanced DNA-based target identification and candidate molecule design capabilities, generating small molecule drug candidates across multiple disease areas including inflammation, oncology, neurodegeneration and addictive disorders. Our commercially attractive portfolio ranges from early-stage novel target opportunities to late-stage Drug Discovery programmes ready for out-licensing to partners and we have two commercially partnered programmes with one candidate in clinical development.

We collaborate with leading pharmaceutical and life sciences companies to enrich our expertise and take our assets through pre-clinical and clinical development. Through early-stage revenue-generating licensing deals, we realise returns from our high value pre-clinical assets which are reinvested to maximise the value of our Drug Discovery portfolio.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHUKARROUUKUAR

(END) Dow Jones Newswires

September 29, 2023 06:14 ET (10:14 GMT)

C4x Discovery (LSE:C4XD)
Gráfica de Acción Histórica
De Abr 2024 a May 2024 Haga Click aquí para más Gráficas C4x Discovery.
C4x Discovery (LSE:C4XD)
Gráfica de Acción Histórica
De May 2023 a May 2024 Haga Click aquí para más Gráficas C4x Discovery.